Tenapanor 50 MG

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 YearsNCT05643534ArdelyxPhase 3Completed2026-08-20Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.